Skip to main content
Fig. 1 | Journal of Experimental & Clinical Cancer Research

Fig. 1

From: MiR-23b targets cyclin G1 and suppresses ovarian cancer tumorigenesis and progression

Fig. 1

Correlation of MIR23B and CCNG1 mRNA expression with pathogenesis and aggressiveness of ovarian carcinoma. a MIR23B mRNA expression was significantly lower in the ovarian carcinomas and borderline ovarian tumors than in the normal ovarian tissues and benign tumors; b there were significant differences in expression among age and d pathological subtype (mucinous vs. other types) in the ovarian carcinoma tissues. c There were no significant differences among FIGO stage (I/II vs. III/IV) in ovarian carcinoma. e CCNG1 mRNA expression was significantly lower in the normal ovarian tissues and benign ovarian tumors than in the ovarian carcinomas. *p < 0.05 vs. normal ovarian tissues; # p < 0.05 vs. benign ovarian tumors. No = Normal ovarian tissues, Be = benign ovarian tumors, Bo = borderline ovarian tumors, Om = omentum tumors, Mu = mucinous carcinoma, Ser = serous carcinoma

Back to article page